FDA panel votes 15-1-1 that Abbott's (ABT) Humira benefit is meaningful
Go back to FDA panel votes 15-1-1 that Abbott's (ABT) Humira benefit is meaningful| Abbott Laboratories (NYSE: ABT) | Delayed: 92.11 -1.82 (1.94%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $93.93 | 52 Week High | $46.38 | |||
| Open | $93.95 | 52 Week Low | $36.00 | |||
| Day High | $94.10 | P/E | 61.41 | |||
| Day Low | $91.64 | EPS | $1.50 | |||
| Volume | 11,756,051 | |||||
